+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and venous thromboembolic disease prophylaxis



Statins and venous thromboembolic disease prophylaxis



Cardiology in Review 21(6): 295-299



Statins have dramatically improved the treatment of hyperlipidemia and cardiovascular disease through its inhibition of hydroxymethylglutaryl-coenzyme A reductase. Although its main effect has long been known, much is yet to be understood about the wide and varied pleiotropic properties of statins. Some studies have demonstrated that statins contain antiplatelet, antithrombotic, antiinflammatory, cardioprotective, and neuroprotective properties independent of their ability to lower plasma low-density lipoprotein cholesterol. More recently, statins have been used in novel ways in the treatment of Alzheimer disease, sepsis, pneumonia, and bacteremia. In 2000, it was first suggested that statins could decrease the incidence of venous thromboembolisms (VTEs). A recent publication showed that not only do statins lower the incidence of deep vein thrombosis and pulmonary embolism, but they do so in a dose-dependent manner. Although there is certainly strong evidence demonstrating that statins do indeed lower VTEs, the mechanism is not understood. Possible hypotheses include their antiinflammatory and antithrombotic properties. With only one randomized clinical trial available, further studies must be conducted before routinely recommending statins for prophylaxis of VTEs.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911910

Download citation: RISBibTeXText

PMID: 23707992

DOI: 10.1097/CRD.0b013e31829cae2d


Related references

Prophylaxis against venous thromboembolic disease: costs and controversy. Journal of Bone and Joint Surgery. American Volume 84-A(12): 2306-2307, 2002

Prophylaxis of venous thromboembolic disease following hip and knee surgery. Journal of Bone and Joint Surgery. American Volume 68(1): 146-150, 1986

Prophylaxis of venous thromboembolic disease in the critical patient. Revista de Enfermeria 36(1): 18-23, 2013

Warfarin prophylaxis for orthopaedic venous thromboembolic disease. Instructional Course Lectures 51: 491-498, 2002

Future directions in prophylaxis and treatment of venous thromboembolic disease. Medicina Clinica 131 Suppl 2: 70-72, 2009

Venous thromboembolic disease prophylaxis among general surgeons in Malaysia. Asian Journal of Surgery 28(2): 125-130, 2005

Bioinformatics analysis of microRNAs related to blood stasis syndrome in diabetes mellitus patients. Bioscience Reports, 2018

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews (): Cd001689-Cd001689, 2010

Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis, and diagnosis. Clinical Orthopaedics and Related Research: 212-231, 1989

Prophylaxis of venous thromboembolic disease. SEPAR's Pulmonary Thromboembolism Group. Archivos de Bronconeumologia 32(7): 348-356, 1996

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews (): Cd001689-Cd001689, 2014

Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur. Canadian Journal of Surgery. Journal Canadien de Chirurgie 22(5): 468-472, 1979

Prophylaxis of venous thromboembolic disease in patients after the proximal femoral surgery. Casopis Lekaru Ceskych 144(7): 455-458, 2005

Coinfection with Tritrichomonas foetus and Giardia duodenalis in Two Cats with Chronic Diarrhea. Case Reports in Veterinary Medicine 2016: 5705168-5705168, 2018

Practice of prophylaxis for venous thromboembolic disease: survey of health professionals in Ouagadougou. Pan African Medical Journal 19: 395-395, 2015